HCM FY 2023 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$838M+96.5% YoY

Gross Profit

$454M54.1% margin

Operating Income

$18M2.2% margin

Net Income

$101M12.0% margin

EPS (Diluted)

$0.60

Cash Flow

Operating Cash Flow

$219M

Free Cash Flow

$187M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$536M

Stockholders' Equity

$731M

Cash & Equivalents

$284M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$838M	$426M	+96.5%
Gross Profit	$454M	$115M	+293.3%
Operating Income	$18M	-$410M	+104.5%
Net Income	$101M	-$361M	+127.9%